Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
Mayo Clinic, Phoenix, Arizona University of Colorado Denver, Aurora, Colorado Mayo Clinic, Jacksonville, Florida The University of Chicago Medical Center, Chicago, Illinois University of Iowa, Iowa City, Iowa Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky Astera Cancer Care, East Brunswick, New Jersey Icahn School of Medicine at Mount Sinai, New York, New York Duke University Medical Center, Durham, North Carolina Medical University of South Carolina, Charleston, South Carolina Prisma Health, Greenville, South Carolina LDS Hospital - lntermountain Health, Salt Lake City, Utah Canada
Hôpital Maisonneuve Rosemont, Montreal, Quebec